Fri, Jan 30, 2015, 7:31 AM EST - U.S. Markets open in 1 hr 59 mins


% | $
Quotes you view appear here for quick access.

ImmunoCellular Therapeutics, Ltd. Message Board

  • troyanderson747 troyanderson747 Oct 19, 2012 11:52 AM Flag

    For those that have gotten hit hard by this stock

    If you've gotten hurt, I recommend staying in another 4-6 months until phase 2 data. but I don't feel this will move up anytime soon.

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • blame it on the "microwave oven"..........We don't like waiting for anything..........including profits.

      imuc has not been this low since last feb., obviously, a lot of good people in the red,.........This is not going to last - I'm not calling for big upside, maybe $2.50 ?? by year end. - I listed catylsts yesterday, will repeat them, cause I repeat myself in real life too. ;)

      -the announcement of "offering closed" next week should create an upward trend. I garantee the over-allotment will be purchased.

      - the start of a ph I trial this quarter-
      - ceo is an absolute must, hopefully before year-end.

      -usually warrants have a 6 mo. hold, immediate exercise with this deal, bummer. [manish never would have agreed to that bull]

      - Long term outlook, if DSMC recommends continue, futility stop is off the table.- This will be viewed by "big money" as a less risky investment, maybe putting buying pressure on shares.

      - 7, 8 mo.? after dsmc recommendation,... . I did see an article calling for $18. a share with a stat sig results ........I'm in no position to argue [ha]

      2 immunotherapy trials read out early 2013, - this will absolutely effect imuc share price, up or down.- .........i read, alot;.......- the ict-107 asco abstract, etc., imho, i believe this vaccine makes it.


0.688+0.008(+1.18%)Jan 29 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.